Latest Anxiolytics Stories

Certain types of medications given to the elderly could add to their risk of falling, according to a new study.Researchers in France conducted a 4-year study of 6343 elderly men and women who were taking an anti-anxiety drug. Participants had an average age of 74 years."Falls and associated injuries remain a major public health problem," researchers wrote.  "With little evidence that deaths and serious injuries from falls are declining, despite a strong focus in research and practice...

RICHMOND, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced it will report results for its quarter ended June 30, 2009 on Friday, August 14, 2009, prior to the opening of the market. A conference call to review the results will begin at 8:30 a.m. ET (5:30 a.m....

In Spain, 24 percent of women use antidepressants and 31 percent use tranquillizers -- sometimes used to help people sleep, researchers said. Lead author Sonsoles Perez of the Las Aguilas Health Centre in Madrid and colleagues studied 121 women in Madrid ages 25-65 using family dysfunction surveys and the additive scale used to evaluate social readjustment. The psychopharmaceuticals analyzed were antidepressants and benzodiazepines -- sedatives, anxiety reducing, anti-convulsant or...

Psychopharmaceutical use has risen over recent years. This is fact, but what is not clear is the reason why. Researchers from four Madrid-based health centers have shown that family conflict is not a significant factor. However, the results published in the journal Atención Primaria are striking: in Spain, 24% of women take antidepressants and more than 30% take tranquilizers."The use of psychopharmaceuticals is often related to family or work-related problems. We wanted to see if...

RICHMOND, Calif., July 22 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, announced today that Glenn A. Oclassen, President & Chief Executive Officer, is scheduled to present at the BMO Capital Markets Healthcare Conference in New York City on Wednesday, August 5, 2009 at 4:00 p.m.,...

UC Irvine anesthesiology study finds melatonin reduces emergence delirium ratesA scary unknown for many children, the prospect of surgery can cause intense preoperative anxiety. While some amount of stress is normal, what many parents do not know is that extreme anxiety before surgery can contribute to the occurrence of emergence delirium, a distressing incidence of acute behavioral changes experienced when "waking up" from anesthesia.Now in the July issue of Anesthesiology,...

 Some people who take the fast-acting sleep-aid zolpidem (Ambien) have been observed walking, eating, talking on the phone and even driving while not fully awake. Many often don't remember doing any of these activities the next morning. Similarly, this drug has been shown to awaken the minimally conscious into a conscious state. A new study by Georgetown University Medical Center (GUMC) researchers may help explain why these "awakenings" occur.The study, published online in the...

In Germany, a group of researchers believe they may have discovered a more sophisticated anti-anxiety drug capable of controlling panic attacks without the hefty side effects associated with most currently available treatments. Diazepam, the active ingredient in the popular drug Valium, has been used for more than 40 years to treat acute anxiety symptoms.  Though highly effective in helping patients manage panic attacks, Valium is frequently accompanied by a number of unpleasant side...

 A research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, is the first demonstration of a specific neurochemical abnormality in adults with primary insomnia (PI), providing greater insight to the limited understanding of the condition's pathology.Results indicate that gamma-aminobutyric acid (GABA), the most common inhibitory transmitter in the brain, is reduced by nearly 30 percent in individuals...

Analyses of Efficacy and Absence of Rebound Effect in a Clinical Study of Intermezzo(R) (Zolpidem Tartrate Sublingual Tablet 3.5 mg) to Treat Middle-of-the-Night (MOTN) Awakening on an As-Needed Basis RICHMOND, Calif., June 9 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, announced today...